Your browser doesn't support javascript.
loading
Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping.
Chikersal, Prerna; Venkatesh, Shruthi; Masown, Karman; Walker, Elizabeth; Quraishi, Danyal; Dey, Anind; Goel, Mayank; Xia, Zongqi.
Afiliação
  • Chikersal P; School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States.
  • Venkatesh S; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  • Masown K; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  • Walker E; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  • Quraishi D; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  • Dey A; Information School, University of Washington, Seattle, Seattle, WA, United States.
  • Goel M; School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States.
  • Xia Z; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
JMIR Ment Health ; 9(8): e38495, 2022 Aug 24.
Article em En | MEDLINE | ID: mdl-35849686
ABSTRACT

BACKGROUND:

The COVID-19 pandemic has broad negative impact on the physical and mental health of people with chronic neurological disorders such as multiple sclerosis (MS).

OBJECTIVE:

We presented a machine learning approach leveraging passive sensor data from smartphones and fitness trackers of people with MS to predict their health outcomes in a natural experiment during a state-mandated stay-at-home period due to a global pandemic.

METHODS:

First, we extracted features that capture behavior changes due to the stay-at-home order. Then, we adapted and applied an existing algorithm to these behavior-change features to predict the presence of depression, high global MS symptom burden, severe fatigue, and poor sleep quality during the stay-at-home period.

RESULTS:

Using data collected between November 2019 and May 2020, the algorithm detected depression with an accuracy of 82.5% (65% improvement over baseline; F1-score 0.84), high global MS symptom burden with an accuracy of 90% (39% improvement over baseline; F1-score 0.93), severe fatigue with an accuracy of 75.5% (22% improvement over baseline; F1-score 0.80), and poor sleep quality with an accuracy of 84% (28% improvement over baseline; F1-score 0.84).

CONCLUSIONS:

Our approach could help clinicians better triage patients with MS and potentially other chronic neurological disorders for interventions and aid patient self-monitoring in their own environment, particularly during extraordinarily stressful circumstances such as pandemics, which would cause drastic behavior changes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JMIR Ment Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JMIR Ment Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos